Effects of Intermitted Theta Burst Stimulation (iTBS) on Motor Recovery of Upper Extremity in Chronic Stroke Patients
NIMBLE
Neuroplastic Changes and Effects of Intermittent Theta Burst Stimulation (iTBS) on Motor Recovery of Upper and Lower Extremity in Chronic Stroke Patients
1 other identifier
interventional
48
1 country
1
Brief Summary
This study aims to evaluate the effects and clinical feasibility of non-invasive brain stimulation protocols, specifically intermittent Theta Burst Stimulation, as part of rehabilitation interventions for motor recovery of upper extremity in the chronic phase after stroke. It also seeks to explore the underlying mechanisms by investigating changes of functional and structural brain networks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Nov 2025
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2025
CompletedFirst Posted
Study publicly available on registry
July 18, 2025
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
November 21, 2025
August 1, 2025
5.1 years
July 9, 2025
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fugl-Meyer Assessment - Upper Extremity
used to quantify recovery of sensorimotor function in the upper extremity after a stroke. It is a 63 item test scored on a 3-level ordinal scale. The score ranges from 0 to 126 points. A higher score indicates recovery of sensorimotor function.
At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Secondary Outcomes (14)
Modified Ashworth Scale (MAS)
At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Neuroflexor
At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Box and Block Test (BBT)
At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Action Research Arm Test (ARAT)
At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Dextrain Manipulandumâ„¢
At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
- +9 more secondary outcomes
Other Outcomes (3)
National Institutes of Health Stroke Scale (NIHSS)
At baseline
Barthel Index (BI)
At baseline.
Theoretical Framework of Acceptability questionnaire
After completion of the 5 week intervention to assess acceptability.
Study Arms (2)
Ipsilesional motor cortex iTBS and conventional rehabilitation
EXPERIMENTALThe experimental group will receive intermittent theta burst stimulation on the ipsilesional motor cortex followed by 45 minutes of conventional rehabilitation interventions involving the upper extremity led or instructed by a physiotherapist.
Ipsilesional motor cortex sham-iTBS and conventional rehabilitation
SHAM COMPARATORThe placebo group will receive sham intermittent theta burst stimulation on the ipsilesional motor cortex followed by 45 minutes of conventional rehabilitation interventions involving the lower extremity led or instructed by a physiotherapist.
Interventions
iTBS protocol: 600 pulses at 80% of AMT for 190 sec on the ipsilesional motor cortex, targeted with the support of a neuronavigational system, 15 sessions over a period of 5 weeks
It is identical to its active version, replicates operational sounds, and delivers a very shallow magnetic field to mimic the sensation of magnetic stimulation
Eligibility Criteria
You may qualify if:
- Age over 18
- Chronic stroke (\>6 months)
- Residual hemiparesis FM-UE\>17
You may not qualify if:
- Metal implants
- Epilepsy/seizures
- Pregnancy
- Claustrophobia (related to MRIs exams)
- Severe cognitive impairment
- Untreated or unstable depression/anxiety
- Other disabilities prohibiting intensive physical training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Danderyd Hospitallead
- Karolinska Institutetcollaborator
Study Sites (1)
Department of Rehabilitation Medicine, Danderyd Hospital, Danderyd, Stockholm 18288, Stockholm
Stockholm, Sweden
Related Publications (8)
Lemon RN. Descending pathways in motor control. Annu Rev Neurosci. 2008;31:195-218. doi: 10.1146/annurev.neuro.31.060407.125547.
PMID: 18558853BACKGROUNDZhang JJ, Bai Z, Fong KNK. Priming Intermittent Theta Burst Stimulation for Hemiparetic Upper Limb After Stroke: A Randomized Controlled Trial. Stroke. 2022 Jul;53(7):2171-2181. doi: 10.1161/STROKEAHA.121.037870. Epub 2022 Mar 23.
PMID: 35317611BACKGROUNDZhang JJ, Sui Y, Sack AT, Bai Z, Kwong PWH, Sanchez Vidana DI, Xiong L, Fong KNK. Theta burst stimulation for enhancing upper extremity motor functions after stroke: a systematic review of clinical and mechanistic evidence. Rev Neurosci. 2024 Apr 29;35(6):679-695. doi: 10.1515/revneuro-2024-0030. Print 2024 Aug 27.
PMID: 38671584BACKGROUNDJiang T, Wei X, Wang M, Xu J, Xia N, Lu M. Theta burst stimulation: what role does it play in stroke rehabilitation? A systematic review of the existing evidence. BMC Neurol. 2024 Feb 1;24(1):52. doi: 10.1186/s12883-023-03492-0.
PMID: 38297193BACKGROUNDvan Lieshout ECC, van der Worp HB, Visser-Meily JMA, Dijkhuizen RM. Timing of Repetitive Transcranial Magnetic Stimulation Onset for Upper Limb Function After Stroke: A Systematic Review and Meta-Analysis. Front Neurol. 2019 Dec 3;10:1269. doi: 10.3389/fneur.2019.01269. eCollection 2019.
PMID: 31849827BACKGROUNDLefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipovic SR, Hummel FC, Jaaskelainen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schonfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5.
PMID: 25034472BACKGROUNDChristiansen MG, Senko AW, Anikeeva P. Magnetic Strategies for Nervous System Control. Annu Rev Neurosci. 2019 Jul 8;42:271-293. doi: 10.1146/annurev-neuro-070918-050241. Epub 2019 Apr 2.
PMID: 30939100BACKGROUNDFan H, Song Y, Cen X, Yu P, Biro I, Gu Y. The Effect of Repetitive Transcranial Magnetic Stimulation on Lower-Limb Motor Ability in Stroke Patients: A Systematic Review. Front Hum Neurosci. 2021 Sep 1;15:620573. doi: 10.3389/fnhum.2021.620573. eCollection 2021.
PMID: 34539362BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanne Palmcrantz, PhD, Associate Professor
Dep of Clinical Sciences, Karolinska Institutet
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Associate Professor, Reg Physiotherapist
Study Record Dates
First Submitted
July 9, 2025
First Posted
July 18, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
November 21, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share